Cruentaren A Binds F1F0 ATP Synthase To Modulate the Hsp90 Protein Folding Machinery
Citations Over TimeTop 22% of 2014 papers
Abstract
The molecular chaperone Hsp90 requires the assistance of immunophilins, co-chaperones, and partner proteins for the conformational maturation of client proteins. Hsp90 inhibition represents a promising anticancer strategy due to the dependence of numerous oncogenic signaling pathways upon Hsp90 function. Historically, small molecules have been designed to inhibit ATPase activity at the Hsp90 N-terminus; however, these molecules also induce the pro-survival heat shock response (HSR). Therefore, inhibitors that exhibit alternative mechanisms of action that do not elicit the HSR are actively sought. Small molecules that disrupt Hsp90-co-chaperone interactions can destabilize the Hsp90 complex without induction of the HSR, which leads to inhibition of cell proliferation. In this article, selective inhibition of F1F0 ATP synthase by cruentaren A was shown to disrupt the Hsp90-F1F0 ATP synthase interaction and result in client protein degradation without induction of the HSR.
Related Papers
- → The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones(2011)497 cited
- → Chaperone Function of Hsp90-Associated Proteins(1996)374 cited
- → The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding(2016)76 cited
- → Impact of Posttranslational Modifications on the Anticancer Activity of Hsp90 Inhibitors(2015)44 cited
- → Structure and function of molecular chaperones: Functions of HSP90, a major stress protein(1998)